Figures & data
Table 1 Criteria for enrollment in the HIP studyCitation3
Table 2 Demographic and baseline characteristics
Table 3 Cumulative hip fracture incidence (Kaplan-Meier) 0–3 years and hip fracture efficacy of risedronate
Register now or learn more
Open access
Table 1 Criteria for enrollment in the HIP studyCitation3
Table 2 Demographic and baseline characteristics
Table 3 Cumulative hip fracture incidence (Kaplan-Meier) 0–3 years and hip fracture efficacy of risedronate
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.